On May 19, 2025, Deputy Attorney General Todd Blanche issued a memorandum titled Civil Rights Fraud Initiative announcing the Department of Justice’s (DOJ) plan to use the False Claims Act (FCA) to “aggressively” pursue...more
5/23/2025
/ Affirmative Action ,
Anti-Discrimination Policies ,
Colleges ,
Corporate Counsel ,
Department of Justice (DOJ) ,
Diversity and Inclusion Standards (D&I) ,
Educational Institutions ,
Enforcement Actions ,
Executive Orders ,
False Claims Act (FCA) ,
Relators ,
Reverse Discrimination ,
Risk Management ,
Students for Fair Admissions v Harvard College ,
Trump Administration ,
Universities
At the Federal Bar Association’s annual qui tam conference in Washington, D.C. on Feb. 20, 2025, the Deputy Assistant Attorney General for the Department of Justice’s (DOJ) Commercial Litigation Branch, Michael Granston, said...more
2/24/2025
/ Compliance ,
Department of Justice (DOJ) ,
Enforcement Actions ,
False Claims Act (FCA) ,
Fraud ,
Government Agencies ,
Healthcare ,
Healthcare Fraud ,
International Trade ,
Regulatory Agenda ,
Trump Administration
The Trump administration has taken significant action this week to overhaul the executive branch’s long-standing policy toward the prosecution of white collar offenses. First, a memo issued by newly confirmed U.S. Attorney...more
2/12/2025
/ Anti-Corruption ,
Bribery ,
Corporate Governance ,
Corporate Misconduct ,
Corruption ,
Criminal Prosecution ,
Department of Justice (DOJ) ,
Donald Trump ,
Enforcement Actions ,
Executive Orders ,
Foreign Corrupt Practices Act (FCPA) ,
Regulatory Agenda ,
Trump Administration ,
White Collar Crimes
Compared with other issues, healthcare enforcement during President-elect Donald Trump’s upcoming second term has received little attention. When he takes office again on January 20, should industry actors like pharmaceutical...more
1/6/2025
/ Anti-Kickback Statute ,
Bad Actors ,
Centers for Medicare & Medicaid Services (CMS) ,
Clinical Laboratories ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Enforcement ,
Enforcement Actions ,
False Claims Act (FCA) ,
Healthcare ,
Healthcare Fraud ,
Hospitals ,
Pharmaceutical Industry ,
Presidential Nominations ,
Trump Administration